Global pharma giants push for weight-loss drugs to be added to PBS
Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the ...
Eli Lilly's direct drug sales alone may not upend the industry, but others could follow suit
Lilly's new platform comes as other companies move to disrupt the drug system in some way, in part as they face more ...
pharmaphorum20h
Lilly's Alzheimer's drug gets UK nod, but no NHS funding
The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy Kisunla today, but the drug is too expensive to be funded by the NHS, according to cost-effectiveness watchdog NICE.
pharmaphorum20h
FDA blocks early nod for Lilly's Alzheimer's drug donanemab
Lilly's Alzheimer's drug Kisunla is cleared in China Eli Lilly has another approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest drugs market.